Voyantis Raises $41M to Help Companies Transition to Efficient Growth, by Focusing on the RIGHT Customers at the RIGHT Time
11.2.2025 15:33:00 CET | Business Wire | Press release
The round, led by Intel Capital, will further infuse AI into customer acquisition & lifecycle optimization
Voyantis, the AI-driven growth platform for customer acquisition and lifecycle optimization, announced it raised $41M in funding, bringing its total funding to $60M. Voyantis has tripled its ARR two years in a row and the funding will fuel and expedite its rapid growth trajectory. The round was led by Intel Capital with participation from Square Peg, Target Global, Jibe, Redseed, Alicorn, 20Growth, Essential and ICON. Intel Capital Investment Director Lisa Cohen will also join Voyantis’ board of directors to further accelerate the company’s growth.
Voyantis was founded on the premise that evolving global economy fundamentals were causing companies to shift away from growth-at-all-costs strategies towards efficient and fiscally responsible growth practices, with a focus on improving Unit Economics. With a bold mission to reimagine, transform and streamline the whole growth process, Voyantis empowers growth teams to identify, acquire, engage, and retain their most valuable customers. Voyantis combines predictive and prescriptive AI to eliminate the guesswork traditionally involved in assessing a customer’s potential value and delivers the user automated actions on the next steps and execution timing.
“We built Voyantis because we believed that the traditional Growth playbooks were primed to be completely re-written in the AI-era. Our new AI-based approach to Growth, opens up a vast new world for Growth and Acquisition teams,” said Ido Wiesenberg, Co-Founder and CEO of Voyantis. “Our mission is to empower businesses to increase profitability and improve unit economics by leveraging AI to acquire, nurture and retain the right customers for their business based on the platform’s ability to assess the future value of a customer at any given point of time throughout their journey and couple the prediction with the optimal set of actions. We are proud to partner with Intel Capital to redefine how businesses achieve sustainable, healthy and predictable growth.”
Voyantis tripled its customer base in 2024. Companies such as Miro, Rappi and Moneylion rely on Voyantis to automate the acquisition of high-value customers on an individual's lifetime value (LTV) basis, which is predicted and continuously updated at every stage of the journey using anonymized first-party, declarative, engagement, and revenue data. These predictions are then coupled with AI-generated prescriptions that produce targeted actions or incentives executed directly via platforms such as Salesforce and Braze.
"Having worked with our portfolio companies at Intel Capital to increase efficiency over the past few years, we've noticed a broader trend across the market: companies of all sizes are focusing on driving smarter, more intentional campaigns that maximize LTV. Voyantis is positioned to enable and automate this shift, empowering companies to optimize and prioritize acquiring, nurturing and retaining the most valuable customers,“ said Lisa Cohen, Investment Director at Intel Capital. “Voyantis’ ability to productize the connection between predictive and prescriptive AI redefines how businesses unlock customer value. Seeing their customers reporting to their boards based on the Voyantis growth metrics solidified our faith in their ability to help companies grow.”
With offices in the US, EMEA, LATAM and Israel and over 70 employees, Voyantis is on a rapid global growth trajectory. The funding will enable Voyantis to expand hiring efforts across sales, marketing, and delivery teams to optimize GTM strategy and pursue further R&D initiatives.
About Voyantis:
Voyantis helps companies to focus on the RIGHT customers at the RIGHT time - for every step of the customer journey. Voyantis is at the forefront of using AI to transform growth strategies. By leveraging user-level lifetime value (LTV) predictions and AI-generated action prescriptions, Voyantis enables businesses to acquire, retain, and nurture high-value customers with precision and efficiency. Companies such as Miro, Rappi and Moneylion rely on Voyantis’s AI platform to automatically trigger actions such as acquiring the right customers on Google and Meta, allocating incentives to the right customers via Salesforce and Braze, and triggering the right upsell options at the right time for each of their customers.
For more information, visit https://www.voyantis.ai/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211913390/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 17:20:00 CEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 17:00:00 CEST | Press release
Presentations at the 94th European Atherosclerosis Society (EAS) Congress highlight the breadth of evidence for bempedoic acid across a wide range of patient subgroups and background therapies. Real-world data from the MILOS study across multiple European cohorts demonstrate consistent effectiveness and safety profile in routine clinical practice.1,2,3,4 Analysis from the CLEAR Outcomes trial underscores the impact of bempedoic acid on cardiovascular risks, including stroke and venous thromboembolism (VTE).5,6 Daiichi Sankyo Europe’s commitment to "care for every heartbeat" is centred on providing accessible oral treatment options to ensure every patient is given a chance to reach their LDL-C goals. Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom